Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05115721
Other study ID # NMU-FY2021-59
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2022
Est. completion date February 10, 2023

Study information

Verified date February 2022
Source Nanjing Medical University
Contact Zhangbin Yu, PHD
Phone +86-025-52226567
Email yuzhangbin@126.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The now widely used reference interval for pulse oxygen saturation of the neonate after 24 hours of birth has been developed relying on data from low altitude.It is not suitable for neonates at high altitude. At present, no reference interval has been established at high altitude, and the existing studies have many limitations. So this study was designed.


Description:

Knowledge of the reference interval of pulse oxygen saturation (SpO2) in neonates is crucial for accurate identification of neonatal hypoxemia. The now widely used standard was derived from low altitude data, which is not suitable neonates at high altitude. At present, many scholars have paid attention to this problem. But, previous studies still have some limitations. For example, they often only focus on a specific altitude. However, with the increase of altitude, the pulse oxygen saturation decreases in a curve, so their study results are only suitable for this specific altitude and can not be widely used.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date February 10, 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 28 Days
Eligibility Inclusion Criteria: - Healthy singleton term infants with no clinical signs and symptoms (e.g., cyanosis, respiratory distress, heart murmur, etc.). Exclusion Criteria: - 1. Low birth weight (< 2500 g). 2. Need for oxygen. 3.1 or 5 minute Apgar score < 7. 4. Referred to the neonatal intensive care unit or neonatology department for various reasons. 5. Neonates discharged within 24 hours of birth. 6. Neonates diagnosed with congenital diseases in utero. 7. Refusal of consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
It's only observational study. No interventions.

Locations

Country Name City State
China Qinghai Women and Children's Hospital Xining Qinghai

Sponsors (7)

Lead Sponsor Collaborator
Nanjing Medical University Affiliated Hospital of Qinghai University, Geermu People's Hospital, Guoluo Tibetan Autonomous Prefecture People's Hospital, Qinghai Red Cross Hospital, Qinghai Women and Children's Hospital, Yushu Prefecture People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pulse oxygen saturation of healthy neonates at high altitude. Pulse oxygen saturation of the right hand and any foot of healthy neonates born at high altitude will be measured 24 hours after birth. According to the normality of the results, the distribution range will be described by mean ± standard deviation or range interquartile. Altitude level: = 2000m. 24 hours after birth
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06133530 - Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica N/A
Completed NCT02233582 - Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude Phase 1
Active, not recruiting NCT04604249 - Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World
Not yet recruiting NCT05063643 - Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude
Recruiting NCT05474287 - SJOV vs. HFNO for Hypoxia During Procedural Sedation at High Altitudes N/A
Completed NCT06392373 - High Altitude Muscle Recovery N/A
Completed NCT03851744 - High Altitude and Exogenous Carbohydrate Oxidation N/A
Completed NCT01830530 - HIGH Altitude CArdiovascular REsearch in the ANDES Phase 4
Completed NCT06164665 - Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude Phase 4
Recruiting NCT06393998 - CO2 Supplement for Treatment of Acute Mountain Sickness N/A
Not yet recruiting NCT06446427 - The Effect of Acute High Altitude Exposure on Rescuer Performance and Patient Care N/A
Completed NCT04915378 - Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) Patients
Completed NCT04290481 - Oxygen Saturation and Perfusion Index ın Neonates at High Altitude
Completed NCT05798416 - Effect of Inhalation of Low Dose CO2 on Exercise Performance at High Altitude N/A
Completed NCT05715476 - The Effect of Different Altitude Levels on Spinal Anesthesia in Cesarean Section Surgery N/A
Recruiting NCT06152744 - Evaluation of Membrane Lung Function in High-altitude Regions
Recruiting NCT05304923 - Supraglottic Jet Oxygenation and Ventilation for Gastrointestinal Endoscopy at High-altitude N/A
Recruiting NCT04199650 - Definition of ARDS in Qinghai Province: Verification of Berlin Definition Plateau Criteria